Edmond De Rothschild Holding S.A. Biogen Inc. Transaction History

Edmond De Rothschild Holding S.A.

  • $6.04 Billion
  • Q3 2024

A detailed history of Edmond De Rothschild Holding S.A. transactions in Biogen Inc. stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 60,070 shares of BIIB stock, worth $8.65 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
60,070
Previous 60,220 0.25%
Holding current value
$8.65 Million
Previous $14 Million 16.6%
% of portfolio
0.19%
Previous 0.24%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$189.07 - $236.8 $28,360 - $35,520
-150 Reduced 0.25%
60,070 $11.6 Million
Q2 2024

Aug 13, 2024
BUY
$190.52 - $236.72 $102,880 - $127,828
540 Added 0.9%
60,220 $14 Million
Q1 2024

May 08, 2024
BUY
$212.02 - $267.71 $2.45 Million - $3.09 Million
11,547 Added 23.99%
59,680 $12.9 Million
Q4 2023

Feb 12, 2024
SELL
$222.59 - $267.94 $2,671 - $3,215
-12 Reduced 0.02%
48,133 $12.5 Million
Q3 2023

Nov 13, 2023
BUY
$253.3 - $285.89 $5.02 Million - $5.67 Million
19,820 Added 69.97%
48,145 $12.4 Million
Q2 2023

Aug 09, 2023
BUY
$275.25 - $318.06 $25,598 - $29,579
93 Added 0.33%
28,325 $8.07 Million
Q1 2023

May 11, 2023
SELL
$256.56 - $292.34 $1.84 Million - $2.1 Million
-7,178 Reduced 20.27%
28,232 $7.85 Million
Q4 2022

Feb 09, 2023
SELL
$252.44 - $306.72 $941,601 - $1.14 Million
-3,730 Reduced 9.53%
35,410 $9.81 Million
Q3 2022

Nov 09, 2022
SELL
$194.69 - $268.46 $3.47 Million - $4.79 Million
-17,830 Reduced 31.3%
39,140 $10.5 Million
Q2 2022

Aug 12, 2022
SELL
$187.54 - $223.02 $2.02 Million - $2.4 Million
-10,760 Reduced 15.89%
56,970 $11.6 Million
Q1 2022

May 10, 2022
SELL
$193.77 - $244.14 $841,930 - $1.06 Million
-4,345 Reduced 6.03%
67,730 $14.3 Million
Q4 2021

Feb 10, 2022
BUY
$223.92 - $287.77 $2.41 Million - $3.1 Million
10,772 Added 17.57%
72,075 $17.3 Million
Q3 2021

Nov 12, 2021
BUY
$282.99 - $369.05 $4.54 Million - $5.92 Million
16,043 Added 35.45%
61,303 $17.3 Million
Q2 2021

Aug 11, 2021
SELL
$259.0 - $414.71 $259,000 - $414,710
-1,000 Reduced 2.16%
45,260 $15.7 Million
Q1 2021

May 17, 2021
BUY
$242.95 - $284.63 $2.19 Million - $2.56 Million
9,000 Added 24.15%
46,260 $12.9 Million
Q2 2020

Aug 07, 2020
BUY
$258.66 - $342.55 $1.76 Million - $2.34 Million
6,820 Added 22.4%
37,260 $9.97 Million
Q4 2019

Feb 14, 2020
SELL
$220.06 - $304.07 $1.93 Million - $2.67 Million
-8,780 Reduced 22.39%
30,440 $9.03 Million
Q3 2019

Nov 14, 2019
SELL
$217.44 - $243.88 $3.2 Million - $3.59 Million
-14,700 Reduced 27.26%
39,220 $9.13 Million
Q2 2019

Aug 14, 2019
SELL
$219.29 - $241.72 $29,165 - $32,148
-133 Reduced 0.25%
53,920 $12.6 Million
Q1 2019

May 13, 2019
SELL
$216.71 - $338.96 $42,908 - $67,114
-198 Reduced 0.36%
54,053 $12.8 Million
Q4 2018

Feb 14, 2019
BUY
$278.5 - $352.75 $683,717 - $866,001
2,455 Added 4.74%
54,251 $16.3 Million
Q3 2018

Nov 14, 2018
SELL
$293.51 - $383.83 $2.14 Million - $2.8 Million
-7,300 Reduced 12.35%
51,796 $18.3 Million
Q2 2018

Aug 14, 2018
BUY
$257.52 - $306.91 $7,983 - $9,514
31 Added 0.05%
59,096 $17.2 Million
Q1 2018

May 15, 2018
SELL
$260.13 - $367.91 $819,149 - $1.16 Million
-3,149 Reduced 5.06%
59,065 $16.2 Million
Q4 2017

Feb 14, 2018
SELL
$307.64 - $344.58 $4.76 Million - $5.33 Million
-15,469 Reduced 19.91%
62,214 $19.8 Million
Q3 2017

Nov 13, 2017
BUY
$281.15 - $329.69 $21.8 Million - $25.6 Million
77,683
77,683 $24.3 Million

Others Institutions Holding BIIB

# of Institutions
998
Shares Held
130M
Call Options Held
1.12M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email